A yeast-based bioassay for the determination of functional and non-functional estrogen receptors.
The response to endocrine therapy of breast cancer is not entirely predictable from hormone receptor status alone since some point mutated or splicing variants of the estrogen receptor (ER) show altered biological activities. In order to characterize the activities of all forms of ER in a heterogeneous breast tumor, a functional assay in Saccharomyces cerevisiae was developed. Total RNA isolated from breast cancer cells and one breast cancer specimen was reverse transcribed and the ER cDNA was amplified by PCR. The products were then cloned into an expression vector by in vivo homologous recombination in yeast. The yeast strain carries a reporter gene ( ADE2 ) coupled to an estrogen response element. Activation of the reporter by ER yielded white colonies whereas lack of ER activity produced red colonies. This permitted the testing for functionality of individual ER molecules and subsequent analysis by rescuing of the ER expression plasmids and complete DNA sequencing. This simple visual test allows discrimination between wild-type ER, constitutively active ER and inactive ER.
Balmelli-Gallacchi
P
P
Biochemistry/Endocrinology and Biomolecular Tumordiagnostics, Department of Research, University Women's Clinic Basel and Stiftung Tumorbank Basel, CH-4031 Basel, Switzerland.
Schoumacher
F
F
Liu
J W
JW
Eppenberger
U
U
Mueller
H
H
Picard
D
D
D001681:Biological Assay / Q000379:methods*; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism*; D004260:DNA Repair; D004273:DNA, Neoplasm; D005260:Female; D015870:Gene Expression; D017930:Genes, Reporter; D005822:Genetic Vectors; D006801:Humans; D011960:Receptors, Estrogen / Q000235:genetics / Q000378:metabolism*; D012441:Saccharomyces cerevisiae; D014407:Tumor Cells, Cultured
D004273:DNA, Neoplasm; D011960:Receptors, Estrogen